{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:35:08Z","timestamp":1780511708139,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"value":"9781071610152","type":"print"},{"value":"9781071610169","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1016-9_8","type":"book-chapter","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T09:19:23Z","timestamp":1618305563000},"page":"83-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Functional Hemolytic Test for Complement Alternative Pathway Convertase Activity"],"prefix":"10.1007","author":[{"given":"Marloes A. H. M.","family":"Michels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C. A. J.","family":"van de Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Volokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert(L) P. W. J.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"issue":"9","key":"8_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785\u2013797. https:\/\/doi.org\/10.1038\/ni.1923","journal-title":"Nat Immunol"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I\u2014molecular mechanisms of activation and regulation. Front Immunol 6:262. https:\/\/doi.org\/10.3389\/fimmu.2015.00262","journal-title":"Front Immunol"},{"issue":"2\u20133","key":"8_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.molimm.2009.09.005","volume":"47","author":"M Harboe","year":"2009","unstructured":"Harboe M, Garred P, Karlstrom E, Lindstad JK, Stahl GL, Mollnes TE (2009) The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification. Mol Immunol 47(2\u20133):373\u2013380. https:\/\/doi.org\/10.1016\/j.molimm.2009.09.005","journal-title":"Mol Immunol"},{"issue":"3","key":"8_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2249.2004.02627.x","volume":"138","author":"M Harboe","year":"2004","unstructured":"Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004) The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 138(3):439\u2013446. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02627.x","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nri2231","volume":"8","author":"P Gros","year":"2008","unstructured":"Gros P, Milder FJ, Janssen BJ (2008) Complement driven by conformational changes. Nat Rev Immunol 8(1):48\u201358. https:\/\/doi.org\/10.1038\/nri2231","journal-title":"Nat Rev Immunol"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12915-015-0203-8","volume":"13","author":"ET Berends","year":"2015","unstructured":"Berends ET, Gorham RD Jr, Ruyken M, Soppe JA, Orhan H, Aerts PC, de Haas CJ, Gros P, Rooijakkers SH (2015) Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes. BMC Biol 13:93. https:\/\/doi.org\/10.1186\/s12915-015-0203-8","journal-title":"BMC Biol"},{"issue":"6","key":"8_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.imbio.2015.04.006","volume":"221","author":"BP Morgan","year":"2016","unstructured":"Morgan BP (2016) The membrane attack complex as an inflammatory trigger. Immunobiology 221(6):747\u2013751. https:\/\/doi.org\/10.1016\/j.imbio.2015.04.006","journal-title":"Immunobiology"},{"issue":"1","key":"8_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imr.12475","volume":"274","author":"CQ Schmidt","year":"2016","unstructured":"Schmidt CQ, Lambris JD, Ricklin D (2016) Protection of host cells by complement regulators. Immunol Rev 274(1):152\u2013171. https:\/\/doi.org\/10.1111\/imr.12475","journal-title":"Immunol Rev"},{"issue":"10","key":"8_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.15252\/embj.201593673","volume":"35","author":"F Forneris","year":"2016","unstructured":"Forneris F, Wu J, Xue X, Ricklin D, Lin Z, Sfyroera G, Tzekou A, Volokhina E, Granneman JC, Hauhart R, Bertram P, Liszewski MK, Atkinson JP, Lambris JD, Gros P (2016) Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode. Embo J 35(10):1133\u20131149. https:\/\/doi.org\/10.15252\/embj.201593673","journal-title":"Embo J"},{"issue":"2","key":"8_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","volume":"66","author":"M Noris","year":"2015","unstructured":"Noris M, Remuzzi G (2015) Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core curriculum 2015. Am J Kidney Dis 66(2):359\u2013375. https:\/\/doi.org\/10.1053\/j.ajkd.2015.03.040","journal-title":"Am J Kidney Dis"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molimm.2016.01.010","volume":"71","author":"P Iatropoulos","year":"2016","unstructured":"Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G (2016) Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. Mol Immunol 71:131\u2013142. https:\/\/doi.org\/10.1016\/j.molimm.2016.01.010","journal-title":"Mol Immunol"},{"issue":"4","key":"8_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grunfeld JP, Niaudet P, Lesavre P, Fremeaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82(4):454\u2013464. https:\/\/doi.org\/10.1038\/ki.2012.63","journal-title":"Kidney Int"},{"issue":"3","key":"8_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","volume":"15","author":"RJH Smith","year":"2019","unstructured":"Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Jozsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Cordoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM (2019) C3 glomerulopathy - understanding a rare complement-driven renal disease. Nat Rev Nephrol 15(3):129\u2013143. https:\/\/doi.org\/10.1038\/s41581-018-0107-2","journal-title":"Nat Rev Nephrol"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fimmu.2018.00612","volume":"9","author":"M Michels","year":"2018","unstructured":"Michels M, van de Kar N, Okroj M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel L (2018) Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases. Front Immunol 9:612. https:\/\/doi.org\/10.3389\/fimmu.2018.00612","journal-title":"Front Immunol"},{"issue":"3","key":"8_CR15","first-page":"121","volume":"70","author":"D Westra","year":"2012","unstructured":"Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC (2012) A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med 70(3):121\u2013129","journal-title":"Neth J Med"},{"issue":"4","key":"8_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/cjn.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschenes G, Lebranchu Y, Zuber J, Loirat C (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8(4):554\u2013562. https:\/\/doi.org\/10.2215\/cjn.04760512","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"8_CR17","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31(6):E1445\u2013E1460. https:\/\/doi.org\/10.1002\/humu.21256","journal-title":"Hum Mutat"},{"issue":"10","key":"8_CR18","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/cjn.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5(10):1844\u20131859. https:\/\/doi.org\/10.2215\/cjn.02210310","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"8_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.kint.2015.12.003","volume":"89","author":"A Angioi","year":"2016","unstructured":"Angioi A, Fervenza FC, Sethi S, Zhang Y, Smith RJ, Murray D, Van Praet J, Pani A, De Vriese AS (2016) Diagnosis of complement alternative pathway disorders. Kidney Int 89(2):278\u2013288. https:\/\/doi.org\/10.1016\/j.kint.2015.12.003","journal-title":"Kidney Int"},{"issue":"1","key":"8_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0022-1759(91)90130-8","volume":"140","author":"G Servais","year":"1991","unstructured":"Servais G, Walmagh J, Duchateau J (1991) Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50). J Immunol Methods 140(1):93\u2013100","journal-title":"J Immunol Methods"},{"issue":"1","key":"8_CR21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.113.1.348","volume":"113","author":"TA Platts-Mills","year":"1974","unstructured":"Platts-Mills TA, Ishizaka K (1974) Activation of the alternate pathway of human complements by rabbit cells. J Immunol 113(1):348\u2013358","journal-title":"J Immunol"},{"issue":"1","key":"8_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1084\/jem.146.1.22","volume":"146","author":"DT Fearon","year":"1977","unstructured":"Fearon DT, Austen KF (1977) Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. J Exp Med 146(1):22\u201333","journal-title":"J Exp Med"},{"issue":"1","key":"8_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.122.1.75","volume":"122","author":"MD Kazatchkine","year":"1979","unstructured":"Kazatchkine MD, Fearon DT, Austen KF (1979) Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b. J Immunol 122(1):75\u201381","journal-title":"J Immunol"},{"issue":"13","key":"8_CR24","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.molimm.2010.05.007","volume":"47","author":"VP Ferreira","year":"2010","unstructured":"Ferreira VP, Pangburn MK, Cortes C (2010) Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 47(13):2187\u20132197. https:\/\/doi.org\/10.1016\/j.molimm.2010.05.007","journal-title":"Mol Immunol"},{"issue":"1","key":"8_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.12388","volume":"178","author":"AM Blom","year":"2014","unstructured":"Blom AM, Volokhina EB, Fransson V, Stromberg P, Berghard L, Viktorelius M, Mollnes TE, Lopez-Trascasa M, van den Heuvel LP, Goodship TH, Marchbank KJ, Okroj M (2014) A novel method for direct measurement of complement convertases activity in human serum. Clin Exp Immunol 178(1):142\u2013153. https:\/\/doi.org\/10.1111\/cei.12388","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/08916934.2017.1423286","volume":"51","author":"A Urban","year":"2018","unstructured":"Urban A, Borowska A, Felberg A, van den Heuvel L, Stasilojc G, Volokhina E, Okroj M (2018) Gain of function mutant of complement factor B K323E mimics pathogenic C3NeF autoantibodies in convertase assays. Autoimmunity 51(1):18\u201324. https:\/\/doi.org\/10.1080\/08916934.2017.1423286","journal-title":"Autoimmunity"}],"container-title":["Methods in Molecular Biology","The Complement System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1016-9_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:56:44Z","timestamp":1698886604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1016-9_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071610152","9781071610169"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1016-9_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"14 April 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}